Cancer bioinformatics: A new approach to systems clinical medicine

BMC Bioinformatics

Volumn 13, Issue 1, 2012, Pages

  Wu, Duojiao ^a   Rice, Catherine M ^b   Wang, Xiangdong ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b BMC Bioinformatics Executive Editor   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

BIOLOGY; EDITORIAL; HUMAN; NEOPLASM; SYSTEMS BIOLOGY;

COMPUTATIONAL BIOLOGY; HUMANS; NEOPLASMS; SYSTEMS BIOLOGY; TUMOR MARKERS, BIOLOGICAL;

EID: 84862202225     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-13-71     Document Type: Editorial

References (19)

1. Wang XD, Liotta L. Clinical bioinformatics: a new emerging science. J Clin Bioinforma 2011, 1(1):1. 10.1186/2043-9113-1-1, 3097094,3097094, 21884620.
2. Holford ME, McCusker JP, Cheung KH, Krauthammer M. A semantic web framework to integrate cancer omics data with biological knowledge. BMC Bioinformatics 2012, 13(Suppl 1):S10. 10.1186/1471-2105-13-S10-S10, 3382439, 22759415.
3. Ebbert MTW, Bastien RRL, Boucher KM, Martín M, Carrasco E, Caballero R, Stijleman IJ, Bernard PS, Facelli JC. Characterization of uncertainty in the classification of multivariate assays: application to PAM50 centroid-based genomic predictors for breast cancer treatment plans. J Clin Bioinforma 2011, 1:37. 10.1186/2043-9113-1-37, 3275466, 22196354.
4. Laczny C, Leidinger P, Haas J, Ludwig N, Backes C, Gerasch A, Kaufmann M, Vogel B, Katus HA, Meder B, et al. miRTrail - a comprehensive webserver for analyzing gene and miRNA patterns to enhance the understanding of regulatory mechanisms in diseases. BMC Bioinformatics 2012, 13(1):36. 10.1186/1471-2105-13-36, 3352041, 22356618.
5. Kimori Y. Mathematical morphology-based approach to the enhancement of morphological features in medical images. J Clin Bioinforma 2011, 1:33. 10.1186/2043-9113-1-33, 3275547, 22177340.
6. Haustein V, Schumacher U. A dynamic model for tumour growth and metastasis formation. J Clin Bioinforma 2012, (MS: 1377215016594165) in pre-accept.
7. von der Heyde S, Beissbarth T. A new analysis approach of epidermal growth factor receptor pathway activation patterns provides insights into cetuximab resistance mechanisms in head and neck cancer. BMC Medicine 2012, (MS: 2092284597711620) in pre-accept.
8. Wang XD. Role of clinical bioinformatics in the development of network-based Biomarkers. J Clin Bioinforma 2011, 1:28. 10.1186/2043-9113-1-28, 3221619, 22024468.
9. Wu DJ, Zhu D, Xu M, Rong RM, Tang QY, Wang XD, Zhu TY. Analysis of Transcriptional Factors and Regulation Networks in Patients with Acute Renal Allograft Rejection. J Proteome Res 2011, 10(1):175-181. 10.1021/pr100473w, 20812764.
10. Chen H, Song ZJ, Qian MJ, Bai CX, Wang XD. Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study. J Cell Mol Med 2011, Aug 25. doi: 10.1111/j.1582-4934.2011.01416.x.
11. Cun Y, Fröhlich H. Prognostic Gene Signatures for Patient Stratification in Breast Cancer - Accuracy, Stability and Interpretability of Gene Selection Approaches Using Prior Knowledge on Protein-Protein Interactions. BMC Bioinformatics 2012, (MS: 1321151249583179 in pre-accept).
12. Chen H, Wang Y, Bai C, Wang XD. Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation. J Proteomics 2012, 10.
13. Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol 2011, 8:184-187. 10.1038/nrclinonc.2010.227, 21364692.
14. Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004, 306(5696):640-643. 10.1126/science.1104635, 15499008.
15. Tian Q, Price ND, Hood L. Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine. J Intern Med 2012, 271(2):111-121. 10.1111/j.1365-2796.2011.02498.x, 22142401.
16. Ren X, Wang Y, Wang J, Zhang XS. A unified computational model for revealing and predicting subtle subtypes of cancers. BMC Bioinformatics 2012, (MS: 1910002661647107 in pre-accept)..
17. González-Beltrán A, Tagger B, Finkelstein A. Federated ontology-based queries over cancer data. BMC Bioinformatics 2012, 13(Suppl 1):S9. 10.1186/1471-2105-13-S11-S9, 3395172, 22759463.
18. Sawey ET, Chanrion M, Cai C, Wu G, Zhang J, Zender L, Zhao A, Busuttil RW, Yee H, Stein L, et al. Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell 2011, 19(3):347-358. 10.1016/j.ccr.2011.01.040, 3061399, 21397858.
19. Cancer bioinformatics; from therapy design to treatment 2006, Volume 30, Issue 2, 0 pp 287. Publisher: John Wiley & Sons, , Sylvia Nagl, 3413974, 22900176.